National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

m-azidopyrimethamine
An antifolate derived from diaminopyrimidine with cytotoxic properties. With a mechanism of action similar to that of methotrexate (MTX), m-azidopyrimethamine blocks tetrahydrofolate synthesis, resulting in depletion of nucleotide precursors and inhibition of DNA, RNA and protein synthesis. This agent is more lipophilic but less potent than MTX. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:MZP



Previous:Lymphoseek, Lyovac Cosmegen, Lyrica, lyso-thermosensitive liposome doxorubicin, Lysodren
Next:mafosfamide, MAGE-10.A2, MAGE-A3/HPV 16 peptide vaccine, magnesium citrate, magnesium hydroxide

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov